These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 30833898)

  • 21.
    Tanner L; Evans JC; Seldon R; Jordaan A; Warner DF; Haynes RK; Parkinson CJ; Wiesner L
    Antimicrob Agents Chemother; 2019 Nov; 63(11):. PubMed ID: 31427302
    [No Abstract]   [Full Text] [Related]  

  • 22. Nitrofuranyl Methyl Piperazines as New Anti-TB Agents: Identification, Validation, Medicinal Chemistry, and PK Studies.
    Yempalla KR; Munagala G; Singh S; Magotra A; Kumar S; Rajput VS; Bharate SS; Tikoo M; Singh GD; Khan IA; Vishwakarma RA; Singh PP
    ACS Med Chem Lett; 2015 Oct; 6(10):1041-6. PubMed ID: 26487909
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Naphthoquinones isolated from Diospyros anisandra exhibit potent activity against pan-resistant first-line drugs Mycobacterium tuberculosis strains.
    Uc-Cachón AH; Borges-Argáez R; Said-Fernández S; Vargas-Villarreal J; González-Salazar F; Méndez-González M; Cáceres-Farfán M; Molina-Salinas GM
    Pulm Pharmacol Ther; 2014 Feb; 27(1):114-20. PubMed ID: 23968826
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Activities and Secretion of Cytokines Caused by Delamanid on Macrophages Infected by Multidrug-Resistant
    Lyu XL; Lin TT; Gao JT; Jia HY; Zhu CZ; Li ZH; Dong J; Sun Q; Shu W; Pan LP; Zhang ZD; Li Q
    Front Immunol; 2021; 12():796677. PubMed ID: 35003120
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quinolone-isoniazid hybrids: synthesis and preliminary
    Beteck RM; Seldon R; Jordaan A; Warner DF; Hoppe HC; Laming D; Legoabe LJ; Khanye SD
    Medchemcomm; 2019 Feb; 10(2):326-331. PubMed ID: 30881619
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Medicinal Chemistry of Chalcones as Anti-
    Rodríguez-Silva CN; Prokopczyk IM; Dos Santos JL
    Mini Rev Med Chem; 2022; 22(16):2068-2080. PubMed ID: 35156577
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of Anti-tuberculosis Compounds From Aurone Analogs.
    Yang D; Taylor ZE; Handy S; Li S; Liu J; Stabenow J; Zalduondo L; Jonsson CB; Altman E; Kong Y
    Front Microbiol; 2020; 11():1004. PubMed ID: 32508798
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Indole Derivatives as Anti-Tubercular Agents: An Overview on their Synthesis and Biological Activities.
    Reddy GS; Pal M
    Curr Med Chem; 2021; 28(22):4531-4568. PubMed ID: 32951569
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis, Structure-Activity Relationship, and Mechanistic Studies of Aminoquinazolinones Displaying Antimycobacterial Activity.
    Akester JN; Njaria P; Nchinda A; Le Manach C; Myrick A; Singh V; Lawrence N; Njoroge M; Taylor D; Moosa A; Smith AJ; Brooks EJ; Lenaerts AJ; Robertson GT; Ioerger TR; Mueller R; Chibale K
    ACS Infect Dis; 2020 Jul; 6(7):1951-1964. PubMed ID: 32470286
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design, synthesis, and structure-activity relationship studies of tryptanthrins as antitubercular agents.
    Hwang JM; Oh T; Kaneko T; Upton AM; Franzblau SG; Ma Z; Cho SN; Kim P
    J Nat Prod; 2013 Mar; 76(3):354-67. PubMed ID: 23360475
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comprehensive physicochemical, pharmacokinetic and activity profiling of anti-TB agents.
    Lakshminarayana SB; Huat TB; Ho PC; Manjunatha UH; Dartois V; Dick T; Rao SP
    J Antimicrob Chemother; 2015 Mar; 70(3):857-67. PubMed ID: 25587994
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of minor groove binders (MGBs) as novel anti-mycobacterial agents and the effect of using non-ionic surfactant vesicles as a delivery system to improve their efficacy.
    Hlaka L; Rosslee MJ; Ozturk M; Kumar S; Parihar SP; Brombacher F; Khalaf AI; Carter KC; Scott FJ; Suckling CJ; Guler R
    J Antimicrob Chemother; 2017 Dec; 72(12):3334-3341. PubMed ID: 28961913
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Harnessing Biological Insight to Accelerate Tuberculosis Drug Discovery.
    de Wet TJ; Warner DF; Mizrahi V
    Acc Chem Res; 2019 Aug; 52(8):2340-2348. PubMed ID: 31361123
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Design, synthesis, and biological evaluation of novel imidazo[1,2-a]pyridinecarboxamides as potent anti-tuberculosis agents.
    Onajole OK; Lun S; Yun YJ; Langue DY; Jaskula-Dybka M; Flores A; Frazier E; Scurry AC; Zavala A; Arreola KR; Pierzchalski B; Ayitou AJ; Bishai WR
    Chem Biol Drug Des; 2020 Dec; 96(6):1362-1371. PubMed ID: 32515129
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel thiomorpholine tethered isatin hydrazones as potential inhibitors of resistant Mycobacterium tuberculosis.
    Karunanidhi S; Chandrasekaran B; Karpoormath R; Patel HM; Kayamba F; Merugu SR; Kumar V; Dhawan S; Kushwaha B; Mahlalela MC
    Bioorg Chem; 2021 Oct; 115():105133. PubMed ID: 34329993
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Novel Tool to Identify Bactericidal Compounds against Vulnerable Targets in Drug-Tolerant M. tuberculosis found in Caseum.
    Sarathy JP; Xie M; Jones RM; Chang A; Osiecki P; Weiner D; Tsao WS; Dougher M; Blanc L; Fotouhi N; Via LE; Barry CE; De Vlaminck I; Sherman DR; Dartois VA
    mBio; 2023 Apr; 14(2):e0059823. PubMed ID: 37017524
    [TBL] [Abstract][Full Text] [Related]  

  • 37.
    Nair SS; Gaikwad SS; Kulkarni SP; Mukne AP
    Pharmacogn Mag; 2017 Jul; 13(Suppl 2):S209-S215. PubMed ID: 28808382
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preliminary Evaluation of Artemisinin-Cholesterol Conjugates as Potential Drugs for the Treatment of Intractable Forms of Malaria and Tuberculosis.
    Morake M; Coertzen D; Ngwane A; Wentzel JF; Wong HN; Smit FJ; Birkholtz LM; Pietersen RD; Baker B; Wiid I; N'Da DD; Haynes RK
    ChemMedChem; 2018 Jan; 13(1):67-77. PubMed ID: 29193799
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Straightforward conversion of decoquinate into inexpensive tractable new derivatives with significant antimalarial activities.
    Beteck RM; Coertzen D; Smit FJ; Birkholtz LM; Haynes RK; N'Da DD
    Bioorg Med Chem Lett; 2016 Jul; 26(13):3006-3009. PubMed ID: 27210430
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Meropenem-clavulanate has high in vitro activity against multidrug-resistant Mycobacterium tuberculosis.
    Davies Forsman L; Giske CG; Bruchfeld J; Schön T; Juréen P; Ängeby K
    Int J Mycobacteriol; 2015 Mar; 4 Suppl 1():80-1. PubMed ID: 27128620
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.